This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Lamb Weston (LW) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Lamb Weston (LW) and WD-40 (WDFC) have performed compared to their sector so far this year.
3 Reasons Why Growth Investors Shouldn't Overlook Lamb Weston (LW)
by Zacks Equity Research
Lamb Weston (LW) could produce exceptional returns because of its solid growth attributes.
United Natural (UNFI) Gains on Network Optimization, Automation
by Zacks Equity Research
United Natural (UNFI) demonstrates strategic growth through network optimization, e-commerce expansion and value creation initiatives despite a modest decline in retail sales.
Tyson Foods (TSN) Up More Than 15% in 3 Months: Here's Why
by Zacks Equity Research
Tyson Foods' (TSN) growth strategy is based on three main pillars, including driving growth in the core protein platform. Management is focused on merchandising and advertising to support its brands.
The J.M. Smucker (SJM) Gains From Efficient Portfolio, Pricing
by Zacks Equity Research
The J.M. Smucker (SJM) benefits from its core priorities, which include driving commercial excellence and reshaping its portfolio, among others. Pricing aids amid elevated costs.
Conagra (CAG) Navigates a Complex Landscape, Hurt by Volumes
by Zacks Equity Research
Conagra (CAG) witnesses soft volumes due to the slowdown in overall consumption. Additionally, the company has been grappling with cost inflation.
Lamb Weston (LW) Benefits From Pricing & Expansion Efforts
by Zacks Equity Research
Lamb Weston's (LW) top line benefits from robust price/mix. The company's efforts to expand capacity enable it to meet rising demand conditions for snacks and fries effectively.
What Makes Lamb Weston (LW) a New Buy Stock
by Zacks Equity Research
Lamb Weston (LW) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors Heavily Search Lamb Weston (LW): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Lamb Weston (LW) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Stock Market News for Jan 5, 2024
by Zacks Equity Research
U.S. stock markets closed mostly lower on Thursday following strong labor market data.
Compared to Estimates, Lamb Weston (LW) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Lamb Weston (LW) give a sense of how its business performed in the quarter ended November 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Time to Buy Lamb Weston's (LW) Stock After Solid Quarterly Results?
by Shaun Pruitt
After posting favorable results for its fiscal second quarter on Thursday, investors may be wondering if it's time to buy Lamb Weston's (LW) stock.
Lamb Weston (LW) Q2 Earnings & Sales Top Estimates, Up Y/Y
by Zacks Equity Research
Lamb Weston's (LW) second-quarter fiscal 2024 results reflect increased earnings and sales with gains from robust pricing. Management raises fiscal 2024 bottom-line view.
Lamb Weston (LW) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Lamb Weston (LW) delivered earnings and revenue surprises of 3.57% and 2.16%, respectively, for the quarter ended November 2023. Do the numbers hold clues to what lies ahead for the stock?
Lamb Weston (LW) Q2 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Lamb Weston's (LW) second-quarter fiscal 2024 performance is likely to reflect benefits from effective pricing and a solid operating momentum. Capacity expansion efforts are also an upside.
Conagra, Lamb Weston, Walgreens Boots Alliance and Constellation Brands are part of Zacks Earnings Preview
by Zacks Equity Research
Conagra, Lamb Weston, Walgreens Boots Alliance and Constellation Brands are highlights of Zacks Earnings Preview article.
How Will Earnings Estimates Evolve in 2024?
by Sheraz Mian
The economy's resilience in the face of the Fed's extraordinary tightening has been a pleasant surprise. That said, it makes sense for growth to moderate going forward to reflect the cumulative effect of monetary policy tightening.
Lamb Weston (LW) Laps the Stock Market: Here's Why
by Zacks Equity Research
Lamb Weston (LW) closed at $108.13 in the latest trading session, marking a +0.58% move from the prior day.
Limoneira (LMNR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Limoneira (LMNR) delivered earnings and revenue surprises of 0% and 13.01%, respectively, for the quarter ended October 2023. Do the numbers hold clues to what lies ahead for the stock?
General Mills (GIS) Beats Q2 Earnings Estimates
by Zacks Equity Research
General Mills (GIS) delivered earnings and revenue surprises of 8.70% and 3.71%, respectively, for the quarter ended November 2023. Do the numbers hold clues to what lies ahead for the stock?
Lamb Weston (LW) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Lamb Weston (LW) closed at $105.92 in the latest trading session, marking a -1.24% move from the prior day.
Clorox's (CLX) Growth Strategies Seem Encouraging: Here's Why
by Zacks Equity Research
Clorox's (CLX) IGNITE strategy bodes well. The company's pricing and cost-saving initiatives are aiding margins and, in turn, profitability.
Lamb Weston (LW) Rewards Investors With a Dividend Hike
by Zacks Equity Research
Lamb Weston (LW) hikes its quarterly dividend by 29% to 36 cents per share. The hiked dividend is payable on Mar 1, 2024.
Here is What to Know Beyond Why Lamb Weston (LW) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching Lamb Weston (LW) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.